Table 6 Presence of symptoms in COVID-19 negative tested patients with olfactory and gustatory dysfunction (binary scaled)

Number of Patients

184

484

Fever (37.5 °C)

80 (43.48%)

134 (27.69%)

0.0104

Visual Dysfunction

39 (21.20%)

41 (8.47%)

0.0001

Auditory Dysfunction

37 (20.11%)

18 (3.72%)

0.0001

Sensibility Dysfunction

38 (20.65%)

49 (10.12%)

0.0001

Dyspnoea

114 (61.96%)

153 (31.61%)

0.0001

Fatigue

165 (89.67%)

301 (62.19%)

0.0001

Headache

153 (83.15%)

266 (54.96%)

0.0001

Joint Pain

132 (71.74%)

177 (36.57%)

0.0001

Rhinorrhea

132 (71.74%)

220 (45.45%)

0.0001

Cough

139 (75.54%)

239 (49.38%)

0.0001

Pharyngitis

140 (76.09%)

220 (45.45%)

0.0001

Diarrhea

77 (41.85%)

100 (20.66%)

0.0001

Ocular Pruritus

71 (38.59%)

140 (28.93%)

0.0176

 General use of medication

82 (44.57%)

163 (33.68%)

0.0091

 Ibuprofen

45 (24.46%)

92 (19.01%)

0.1192

 Acetaminophen

31 (16.85%)

59 (12.19%)

0.1152

 Aspirin

9 (4.89%)

16 (3.31%)

0.3348

 Metamizole

12 (6.5%)

9 (1.86%)

0.0020

 Diclofenac

1 (0.54%)

0

0.2754

 Ketoprofen

1 (0.54%)

0

0.2754

 Other medication

11 (5.98%)

18 (3.72%)

0.2005

 Pre-existent disease

109 (59.24%)

322 (66.53%)

0.0314

 Stroke

0

2 (0.41%)

1.0000

 Myocardial Infarction

4 (2.17%)

5 (1.03%)

0.2690

 Chronic heart disease

8 (4.35%)

15 (3.10%)

0.4291

 Rheumatological disease

7 (3.80%)

7 (1.45%)

0.0706

 Transplantation

0

3 (0.62%)

0.5651

 Kidney disease

2 (1.09%)

1 (0.21%)

0.1854

 Dialysis

0

0

n.a

 Autoimmune liver disease

0

1 (0.21%)

1.0000

 Liver cirrhosis

1 (0.54%)

1 (0.21%)

0.4753

 Lung disease

23 (12.50%)

49 (10.12%)

0.3763

 Lupus

0

2 (0.41%)

1.0000

 other

52 (28.26%)

108 (22.31%)

0.1077